* USANA Health Sciences Inc USNA.N USNA.K is expected to
show a rise in quarterly revenue when it reports results on
April 27.
* The Salt Lake City, Utah-based company is expected to report
a 13.1% increase in revenue to $301.474 million from $266.62
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for USANA Health Sciences
Inc is for earnings of $1.49 per share. For the same quarter
last year, the company reported earnings of $1.23 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by about 1.4%
in the last three months.
* Wall Street's median 12-month price target for USANA Health
Sciences Inc is $112.5, about 14% above its last closing price
of $96.71.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Dec. 31 2020 1.43 1.43 1.87 Beat 31.1
Sep. 30 2020 1.27 1.27 1.44 Beat 13.8
Jun. 30 2020 1.10 1.08 1.32 Beat 22.2
Mar. 31 2020 0.80 0.84 1.23 Beat 47.3
Dec. 0.99 0.99 1.41 Beat 43.1
31 2019
Sep. 30 2019 0.87 0.86 1.09 Beat 26.3
Jun. 30 2019 0.93 0.93 0.91 Missed -2.2
Mar. 31 2019 0.99 0.99 1.01 Beat 1.7
This summary was machine generated April 24 at 00:54 GMT. All
figures in US dollars unless otherwise stated